| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228306 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
A therapeutic advantage of the hypofractionated compared with the conventional dose schedule for RT of prostate cancer was evident at 90 months in the present study.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eric E. M.D., F.R.C.P. (Edin.), F.R.C.R., F.R.A.N.Z.C.R., Rochelle J. B.Sc. (Hons.), Julie B.H.Sc., Addolorata C. B.Sc. (Hons.), Richard H. M.D., F.R.A.C.P., Jack D.Sc., Ph.D., F.Inst.P.,